Development of Vaccines against SARS-CoV-2 and the consequences related to the emergence of new variants of the virus

• Autores: Lanata-de las Casas, Claudio F., Ecker-Ledesma, Lucie, Cornejo-Cotos, Rubelio E., Celis-Albújar, Carlos R., Díaz-Parra, Carmen del Pilar, Ricalde-Ponce de León, Sheby A., Flores-Salmón, Omar, Ochoa Porras, Mayra, Peña-Peralta, Bia, Gil-Merino, Ana I.
• Formato: artículo
• Fecha de Publicación: 2021
• Institución: Fundación Instituto Hipólito Unanue
• Repositorio: Diagnóstico
• Lenguaje: español
• OAI Identifier: oai:revistadiagnostico.fihu.org.pe:article/305
• Enlace del recurso: https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/305
• Nivel de acceso: acceso abierto
• Materia: SARS-CoV2; COVID-19; coronavirus; vacunas; eficacia; efectividad; variantes de interés; variantes de preocupación; SARS-CoV-2; review; vaccines; efficacy; effectiveness; variants of interest; varians of concerns

The onset of the pandemic caused by the SARS-CoV-2 virus found the world unprepared. However, the reaction to it has been amazing. In just over a year since the virus was recognized, there are hundreds of vaccines in development, some of them already in use in many countries of the world. In this manuscript we review the current status of vaccine development, highlighting those that are under study to evaluate its efficacy or effectiveness. We also review the variants of interest and of concern of the SARS-CoV-2 virus detected until now and what is known about the efficacy of the vaccines against them.